Healstone's goal is to improve global healthcare by making high quality drug and disease identification technologies accessible for diagnostic research and development.
Healstone Biotech was founded in 2016 by Canadian researchers at Vancouver, Canada. Since then, Healstone has been supplying immunological reagents and components for rapid test research and development applications in various countries such as the U.S., Canada, Europe, and China.
Healstone is owned by Healgen Scientific LLC, located in the U.S., and provides critical biological lab services and supplies internally.
Safety
Integrity
Technology
Accessible